Use access key #2 to skip to page content.
$2.35 0.00 (0.00%)
6/9/2008 4:00 PM

Encysive Pharmaceuticals, Inc. (ENCY)

CAPS Rating:
****

A global biopharmaceutical company that engages in the discovery, development and commercialization of novel, synthetic, small molecule compounds to address unmet medical needs.

View All Commentary (ENCY)

Recs

1

Avatar Uresh (75.90) Submitted: 8/08/07 11:41 AM : Outperform Start Price: $1.90 ENCY Score: 40.66

Non U.S revenues will continue to grow. And the FDA appeal process will retify the somewhat committe bias decision. They may lose their lead, but the share will bounce, because the drug has merit. Shame that lives are not as important as favouritism. Self regulated bodies are always a crock. Perhaps in a democratic country, the FDA should not have drug companies as sponsors but the government should back it with tax payers money. A few less bombs to kill and some additional funds to heal?

Report this Post Replies: 0 | Reply

Featured Broker Partners